Brief: Fusion Antibodies Gets R&D Tax Credit From HMRC For FY23
Feb 1 (Reuters) - Fusion Antibodies PLC FAB.L :
* FUSION ANTIBODIES PLC - ANNOUNCES RECEIPT OF AN RESEARCH
AND
DEVELOPMENT TAX CREDIT FROM HMRC IN RESPECT OF FINANCIAL YEAR
ENDED 31 MARCH 2023
* FUSION ANTIBODIES - TAX CREDIT RELATING TO WORK PERFORMED
ON
DEVELOPMENT, OPTIMIZATION OF OPTIMAL PLATFORM, OTHER RESEARCH
AND DEVELOPMENT PROJECTS IN BIOINFORMATICS
Source text for Eikon: ID:nRSA5965Ba
Further company coverage: FAB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM